Patents by Inventor Patrice CANI

Patrice CANI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIPID NANOCAPSULES CHARGED WITH INCRETIN MIMETICS
    Publication number: 20250057922
    Abstract: A lipid nanocapsule for oral administration including a solid lipid outer shell and a lipophilic liquid inner core having reverse micelles loaded with one or more incretin mimetics. Also, a method for treating and/or preventing a disorder associated with a GLP-1 dysfunction, the method including a step of administering the therapeutically effective amount of the lipid to a subject in need thereof.
    Type: Application
    Filed: October 10, 2024
    Publication date: February 20, 2025
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Ana BELOQUI, Yining XU, Véronique PRÉAT, Patrice CANI
  • COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA FOR THE TREATMENT OR PREVENTION OF IBS-RELATED ANXIETY
    Publication number: 20240424031
    Abstract: Disclosed are compositions comprising pasteurized Akkermansia for the treatment or prevention of IBS-related anxiety. Further disclosed is the use of the composition for promoting mental health or reducing anxiety, non-depressive mood disorders or stress in IBS patients. A further object, is the use of the composition for improving the gut-brain axis.
    Type: Application
    Filed: August 2, 2022
    Publication date: December 26, 2024
    Inventors: Patrice CANI, Amandine BROCHOT
  • PREVENTION AND/OR TREATMENT OF REWARD DYSREGULATION DISORDERS
    Publication number: 20240415895
    Abstract: A composition including one or more bacteria selected from the genus Parabacteroides and/or an extract thereof and/or metabolites thereof. Also, the use of this composition in methods of preventing and/or treating reward dysregulation disorders, including mental disorders, neurological disorders, and combinations thereof, by administering this composition to an individual in need thereof.
    Type: Application
    Filed: July 20, 2022
    Publication date: December 19, 2024
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Amandine EVERARD, Alice DE WOUTERS D'OPLINTER, Geoffroy Olivier Ludovic MALLARET, Patrice CANI
  • COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA MUCINIPHILA FOR THE TREATMENT OR PREVENTION OF GUT CONTRACTILITY DISORDERS, IN PARTICULAR DUODENAL CONTRACTION AMPLITUDE DISORDER
    Publication number: 20240350560
    Abstract: Disclosed are compositions comprising pasteurized Akkermansia for the treatment or prevention of gut contractility disorders, in particular for reducing the duodenal amplitude of contractions.
    Type: Application
    Filed: August 2, 2022
    Publication date: October 24, 2024
    Inventors: Patrice CANI, Amandine BROCHOT
  • COMPOSITION COMPRISING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT
    Publication number: 20230405076
    Abstract: Disclosed are composition comprising Akkermansia muciniphila and green tea extract. Further disclosed is the use of the composition for promoting weight loss and reducing visceral fat and improving the gut barrier function in a subject in need thereof.
    Type: Application
    Filed: November 3, 2021
    Publication date: December 21, 2023
    Applicant: THE AKKERMANSIA COMPAN
    Inventors: Patrice CANI, Amandine BROCHOT
  • DYSOSMOBACTER, A NOVEL BACTERIAL GENUS OF THE GASTROINSTESTINAL MICROBIOTA AND USES THEREOF
    Publication number: 20230372412
    Abstract: A bacterium belonging to a novel bacterial genus, Dysosmobacter. Also, the therapeutic, nutraceutical and cosmetic use thereof. The uses include methods for treating a disorder, promoting weight loss, decreasing food intake, increasing muscle mass, decreasing fat mass, increasing satiety, and/or decreasing weight gain associated with food intake in a subject, including administering to the subject at least one isolated bacterium belonging to the genus Dysosmobacter and/or a variant thereof and/or fragments thereof.
    Type: Application
    Filed: May 15, 2023
    Publication date: November 23, 2023
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Patrice CANI, Tiphaine LE ROY
  • , a novel bacterial genus of the gastrointestinal microbiota and uses thereof
    Patent number: 11690879
    Abstract: A bacterium belonging to a novel bacterial genus, Dysosmobacter. Also, the therapeutic, nutraceutical and cosmetic use thereof. The uses include methods for treating a disorder, promoting weight loss, decreasing food intake, increasing muscle mass, decreasing fat mass, increasing satiety, and/or decreasing weight gain associated with food intake in a subject, including administering to the subject at least one isolated bacterium belonging to the genus Dysosmobacter and/or a variant thereof and/or fragments thereof.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: July 4, 2023
    Assignee: UNIVERSITÈ CATHOLIQUE DE LOUVAIN
    Inventors: Patrice Cani, Tiphaine Le Roy
  • LIPID NANOCAPSULES CHARGED WITH INCRETIN MIMETICS
    Publication number: 20220347111
    Abstract: A lipid nanocapsule for oral administration including a solid lipid outer shell and a lipophilic liquid inner core having reverse micelles loaded with one or more incretin mimetics. Also, a method for treating and/or preventing a disorder associated with a GLP-1 dysfunction, the method including a step of administering the therapeutically effective amount of the lipid to a subject in need thereof.
    Type: Application
    Filed: May 27, 2020
    Publication date: November 3, 2022
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Ana BELOQUI, Yining XU, Véronique PRÉAT, Patrice CANI
  • USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20210393704
    Abstract: The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: September 3, 2021
    Publication date: December 23, 2021
    Inventors: Patrice CANI, Amandine EVERARD, Clara BELZER, Willem DE VOS
  • DYSOSMOBACTER, A NOVEL BACTERIAL GENUS OF THE GASTROINTESTINAL MICROBIOTA AND USES THEREOF
    Publication number: 20210338745
    Abstract: A bacterium belonging to a novel bacterial genus, Dysosmobacter. Also, the therapeutic, nutraceutical and cosmetic use thereof. The uses include methods for treating a disorder, promoting weight loss, decreasing food intake, increasing muscle mass, decreasing fat mass, increasing satiety, and/or decreasing weight gain associated with food intake in a subject, including administering to the subject at least one isolated bacterium belonging to the genus Dysosmobacter and/or a variant thereof and/or fragments thereof.
    Type: Application
    Filed: July 10, 2019
    Publication date: November 4, 2021
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Patrice CANI, Tiphaine LE ROY
  • USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20210322489
    Abstract: The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: June 25, 2021
    Publication date: October 21, 2021
    Inventors: Patrice CANI, Amandine EVERARD, Clara BELZER, Willem DE VOS
  • USE OF PASTEURIZED AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20210015876
    Abstract: The present invention relates to pasteurized Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising pasteurized Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of pasteurized Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: June 30, 2020
    Publication date: January 21, 2021
    Inventors: Patrice CANI, Amandine EVERARD, Hubert PLOVIER, Céline DRUART, Willem DE VOS, Clara BELZER
  • Use of pasteurized for treating metabolic disorders
    Patent number: 10736924
    Abstract: The present invention relates to pasteurized Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising pasteurized Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of pasteurized Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: August 11, 2020
    Assignees: UNIVERSITÉ CATHOLIQUE DE LOUVAIN, WAGENINGEN UNIVERSITEIT
    Inventors: Patrice Cani, Amandine Everard, Hubert Plovier, Céline Druart, Willem De Vos, Clara Belzer
  • USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20200237832
    Abstract: The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: December 20, 2019
    Publication date: July 30, 2020
    Inventors: Patrice CANI, Amandine EVERARD, Clara BELZER, Willem DE VOS
  • USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20200237833
    Abstract: The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: December 20, 2019
    Publication date: July 30, 2020
    Inventors: Patrice CANI, Amandine EVERARD, Clara BELZER, Willem DE VOS
  • USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20200155616
    Abstract: The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: December 10, 2019
    Publication date: May 21, 2020
    Inventors: Patrice CANI, Amandine EVERARD, Clara BELZER, Willem DE VOS
  • USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20200121737
    Abstract: The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: December 10, 2019
    Publication date: April 23, 2020
    Inventors: Patrice CANI, Amandine EVERARD, Clara BELZER, Willem DE VOS
  • USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20190282630
    Abstract: The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: May 7, 2019
    Publication date: September 19, 2019
    Inventors: Patrice CANI, Amandine EVERARD, Clara BELZER, Willem DE VOS
  • USE OF PASTEURIZED AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20180250347
    Abstract: The present invention relates to pasteurized Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising pasteurized Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of pasteurized Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: September 9, 2016
    Publication date: September 6, 2018
    Inventors: Patrice CANI, Amandine EVERARD, Hubert PLOVIER, Céline DRUART, Willem DE VOS, Clara BELZER
  • USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
    Publication number: 20150306152
    Abstract: The present invention relates to Akkermansia muciniphila or fragments thereof for treating a metabolic disorder in a subject in need thereof. The present invention also relates to a composition, a pharmaceutical composition and a medicament comprising Akkermansia muciniphila or fragments thereof for treating a metabolic disorder. The present invention also relates to the use of Akkermansia muciniphila or fragments thereof for promoting weight loss in a subject in need thereof.
    Type: Application
    Filed: November 15, 2013
    Publication date: October 29, 2015
    Inventors: Patrice CANI, Amandine EVERARD, Clara BELZER, Willem DE VOS